Circadian therapy in bipolar disorder
what you need to know
If you have bipolar disorder, you have probably noticed that disruptions to your sleep, routine, or schedule can trigger mood episodes. This is not a coincidence; it reflects a fundamental connection between your body's internal clock and your mood. A growing body of research shows that therapies targeting the circadian system, collectively known as chronotherapies, can be powerful tools in managing bipolar disorder.
The Circadian Connection: Why Your Internal Clock Matters
Bipolar disorder is not just a mood disorder; it is also a circadian rhythm disorder. The body's internal clock, governed by a network of genes and brain structures, regulates sleep-wake cycles, hormone secretion, body temperature, energy levels, and mood. In bipolar disorder, this system is fundamentally unstable.
Research has documented that people with bipolar disorder show disruptions in nearly every measurable circadian output: irregular sleep-wake patterns, altered melatonin secretion, abnormal cortisol rhythms, and changes in core body temperature cycling. These disruptions are not just symptoms of mood episodes; they persist during periods of wellness and may actually drive the onset of new episodes.
The International Society for Bipolar Disorders (ISBD) Chronobiology and Chronotherapy Task Force, a panel of 30 international experts from 15 countries, recently reached consensus that circadian dysfunction is involved in the pathophysiology of bipolar disorder and that circadian-based interventions deserve a central role in its management. Despite this evidence, many clinical training programs and practice guidelines have not yet fully incorporated these findings.
1. Bright Light Therapy
Bright light therapy (BLT) involves daily exposure to a light box emitting up to 10,000 lux, typically for 30 minutes per day. Originally developed for seasonal affective disorder, BLT has shown significant promise for bipolar depression.
The ISBD Chronobiology and Chronotherapy Task Force concluded that adjunctive BLT is likely an efficacious acute treatment for bipolar depression. A meta-analysis of six randomized controlled trials found a medium-to-large effect on depressive symptoms (Hedges' g = -0.74). The VA/DoD Clinical Practice Guidelines for bipolar disorder also support light therapy, citing significant improvements in depression severity on the Hamilton Depression Rating Scale.
Key practical points:
- Administer daily, preferably in the morning or at midday
- Start at 15 minutes per day and increase by 15 minutes weekly, up to 30 to 60 minutes
- Clinical improvement is typically observed within 1 to 2 weeks, with response or remission expected by 4 to 6 weeks
- Anti-manic prophylaxis (especially for bipolar I) and clinical monitoring are recommended, as there is a small risk of triggering hypomania or mania, though midday light exposure appears to carry a lower switch risk than morning exposure
2. Wake Therapy (Sleep Deprivation)
Wake therapy, also called therapeutic sleep deprivation, is one of the fastest-acting antidepressant interventions known. It involves staying awake for an extended period (typically 36 hours) to produce a rapid antidepressant effect.
A meta-analysis of 15 studies found an overall response rate of 47.6% for sleep deprivation in bipolar depression. A landmark study of 143 consecutively admitted inpatients with drug-resistant bipolar depression found that combining three cycles of total sleep deprivation with bright light therapy and lithium produced a 70% response rate within one week, and 55% maintained their response at one month. Remarkably, the treatment also produced an immediate and persistent decrease in suicidal ideation.
The challenge with wake therapy is that the antidepressant effect can be lost after recovery sleep. Modern protocols address this by combining sleep deprivation with bright light therapy, sleep phase advance (gradually shifting bedtime earlier), and mood-stabilizing medication, a combination sometimes called "triple chronotherapy." A randomized controlled trial demonstrated that this combination produced significant decreases in depression within 48 hours that were sustained over seven weeks.
3. Dark Therapy and Blue-Light Blocking Glasses
If light can treat depression, can darkness treat mania? This question led to the development of dark therapy: keeping patients in complete darkness for 14 hours per night (6 PM to 8 AM). Early case reports and a pseudorandomized trial showed rapid reductions in manic symptoms, with an effect size of 1.6 after just three days.
Because enforced total darkness is impractical, researchers developed "virtual darkness therapy" using amber-tinted blue-blocking glasses. These glasses prevent blue light wavelengths from reaching the retina, effectively signaling darkness to the brain's master clock. A randomized controlled trial found that manic patients wearing blue-blocking glasses showed a mean decrease of 14.1 points on the Young Mania Rating Scale after one week, compared to just 1.7 points for patients wearing clear control lenses, an extraordinarily large effect size of 1.86.
However, a more recent 2025 randomized controlled trial of 42 inpatients with mania did not replicate these findings, with blue-blocking glasses showing no significant improvement over lightly tinted control lenses. The evidence for this approach is therefore promising but not yet definitive, and further research is needed.
4. Melatonin and Melatonergic Agents
Melatonin, the hormone that signals darkness to the brain, has been studied as an adjunctive treatment for bipolar disorder. A systematic review found that while pilot studies suggested beneficial effects on sleep, depression, and mania, the pooled results from randomized controlled trials were mixed. The largest efficacy signal was for manic symptoms, where adjunctive melatonin showed superior effects versus placebo during acute mania. Melatonin may also have a role in preventing relapse into depression. However, dose-finding studies and larger trials are needed to confirm these findings.
5. Interpersonal and Social Rhythm Therapy (IPSRT)
IPSRT is a psychotherapy designed specifically for bipolar disorder that targets the circadian system through behavioral means. Developed by Ellen Frank and colleagues, IPSRT combines interpersonal psychotherapy with social rhythm therapy to help patients establish and maintain regular patterns of sleep, meals, daily activities, and social interactions.
The rationale is straightforward: life events, both positive and negative, can disrupt daily routines, which in turn destabilize circadian rhythms and trigger mood episodes. By helping patients identify and protect their daily rhythms, IPSRT aims to reduce this vulnerability.
Research has shown that IPSRT can significantly improve social rhythm regularity, reduce depressive and manic symptoms, and enhance social functioning. A 2026 quasi-experimental study found that IPSRT produced sustained improvements in social rhythm stability and social functioning that persisted at three-month follow-up. Earlier research demonstrated that improvement in social rhythm regularity was associated with longer time to episode recurrence.
A JAMA review of bipolar disorder treatment notes that IPSRT focuses on stabilizing circadian rhythms, improving medication adherence, and reducing interpersonal stress, though it acknowledges that the evidence of efficacy is still limited compared to some other psychotherapies.
What This Means for You
Chronotherapy is not a replacement for medication; it is an adjunct. Nearly all studies of chronotherapy in bipolar disorder have been conducted alongside standard mood-stabilizing pharmacotherapy. But the evidence increasingly suggests that addressing the circadian system can meaningfully improve outcomes.
Practical steps to discuss with your provider:
- Protect your sleep-wake schedule. Maintaining consistent bed and wake times, even on weekends, is one of the most important things you can do for mood stability.
- Ask about bright light therapy. If you experience bipolar depression, adjunctive light therapy may accelerate your response to treatment. This should always be done under clinical supervision to monitor for manic switching.
- Consider IPSRT. If you notice that disruptions to your routine trigger mood episodes, a therapy specifically designed to stabilize your daily rhythms may be beneficial.
- Be cautious with blue light at night. While the evidence for blue-blocking glasses in mania is still evolving, minimizing evening screen time and bright light exposure is consistent with good circadian hygiene.
- Track your rhythms. Keeping a daily log of sleep times, wake times, meals, and activities can help you and your provider identify patterns and early warning signs.
The Bottom Line
The connection between circadian rhythms and bipolar disorder is real, well-documented, and increasingly recognized by the international psychiatric community. Chronotherapies, including bright light therapy, wake therapy, dark therapy, melatonergic agents, and IPSRT, represent a growing toolkit of evidence-based interventions that target the biological clock to stabilize mood. While more research is needed for some of these approaches, the overall direction of the science is clear: treating bipolar disorder means treating the clock.
If you are living with bipolar disorder and have not discussed circadian strategies with your provider, it may be worth starting that conversation.
Living with bipolar disorder? Your body clock is part of the treatment.
Alice Tran, PMHNP-BC, provides psychiatric evaluations, medication management, and supportive therapy, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. No referral needed.
Schedule a ConsultationSee Also
Sources
- Gottlieb JF, et al. "The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD Task Force on Chronotherapy and Chronobiology." Bipolar Disorders, 2019.
- Benedetti F, et al. "Rapid treatment response of suicidal symptoms to lithium, sleep deprivation, and light therapy (chronotherapeutics) in drug-resistant bipolar depression." Journal of Clinical Psychiatry, 2014.
- Henriksen TE, et al. "Blue-blocking glasses as additive treatment for mania: a randomized placebo-controlled trial." Bipolar Disorders, 2016.
- Frank E, et al. "Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder." Archives of General Psychiatry, 2005.
- VA/DoD Clinical Practice Guideline for the Management of Bipolar Disorder. healthquality.va.gov
Anh Tran (Alice), PMHNP-BC, FNP-BC
Dual Board-Certified Family and Psychiatric Nurse Practitioner
Alice is a dual board-certified PMHNP and FNP licensed in Virginia, trained under psychiatrist Dr. Errol Segall, MD (50+ years of experience). She treats ADHD, anxiety, depression, and more, in person in Fairfax and via telehealth across Virginia, in English and Vietnamese. Learn more →